Modulation of Cerebral Grey Matter High Energy Phosphate Metabolites in Multiple Sclerosis by Dimethyl Fumarate

Trial Profile

Modulation of Cerebral Grey Matter High Energy Phosphate Metabolites in Multiple Sclerosis by Dimethyl Fumarate

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 04 Oct 2016

At a glance

  • Drugs Dimethyl fumarate
  • Indications Multiple sclerosis
  • Focus Pharmacodynamics
  • Most Recent Events

    • 26 Sep 2016 Status changed from not yet recruiting to recruiting.
    • 11 Jan 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top